Intel broke out its product and foundry financials, showing investors their different margin profiles.
Author: Arthur Bleemer
Cal-Maine sells more eggs than ever, and the stock rallies
Demand for eggs remains strong as people look for an ‘affordable and nutritious protein option,’ Cal-Maine…
Taking Ari Emanuel’s Endeavor Group private is good for the WWE and UFC, this analyst says
Endeavor on Tuesday said that longtime investor Silver Lake was taking the company private in a…
Vanda Pharmaceuticals shares jump 30% after FDA approval of Fanapt for bipolar I disorder
The biopharmaceutical company said Tuesday the latest marketing approval increases the commercial opportunity of the treatment.
Healthcare stocks fade as obesity-drug optimism fades
Healthcare companies fell sharply Monday as ebullience about a new class of weight control drugs subsided.
Rubrik files for IPO as market continues to display signs of unfreezing
Investors hungry for more technology IPOs look to be getting another one soon, as cybersecurity company…
Acorda Therapeutics shares sink nearly 40% after bankruptcy filing
Shares of Acorda Therapeutics fell late Monday after the company said it had filed for bankruptcy…
Nikola’s stock snaps long win streak as EV maker sues Heavy D, founder
Shares of Nikola Corp. snapped a record-tying win streak Monday, amid the electric-vehicle maker’s growing dispute…
Canoo’s downbeat forecast sends stock tumbling, in latest EV setback
EV maker Canoo disappointed with its latest revenue total and outlook.
Two Warner Bros. Discovery directors resign over antitrust concerns
Two Warner Bros. Discovery directors have resigned after antitrust officials raised the issue of them serving…
Nippon Steel’s new president says he’s committed to U.S. Steel acquisition
The new president of Nippon Steel Corp. says he’s determined to push through with the $14.1…
From ‘Ripley’ to ‘The Jinx: Part 2,’ here’s what’s worth streaming in April 2024
Hulu and Netflix are still the best of the bunch in a surprisingly slow month for…